These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37309281)

  • 21. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
    Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
    Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
    Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
    Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
    Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
    [No Abstract]   [Full Text] [Related]  

  • 25. Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion.
    Yang Y; Ma L; Qiao X; Zhang X; Dong SF; Wu MT; Zhai K; Shi HZ
    Transl Lung Cancer Res; 2020 Aug; 9(4):1247-1257. PubMed ID: 32953502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.
    Verma A; Chopra A; Lee YW; Bharwani LD; Asmat AB; Aneez DB; Akbar FA; Lim AY; Chotirmall SH; Abisheganaden J
    Curr Drug Discov Technol; 2016; 13(2):68-76. PubMed ID: 27216707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung.
    Wang S; Chen H; Zhong J; Qin H; Bai H; Zhao J; Wang J
    Lung Cancer; 2019 Sep; 135():116-122. PubMed ID: 31446983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.
    Song Z; Luo W; Zheng H; Zeng Y; Wang J; Chen T
    Adv Healthc Mater; 2021 Jun; 10(12):e2100149. PubMed ID: 33870649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
    Tian T; Li J; Hu W; Sun C; Zhou J
    J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling.
    Guo Z; Xie Z; Shi H; Du W; Peng L; Han W; Duan F; Zhang X; Chen M; Duan J; Lin J; Chen X; Lizaso AA; Han-Zhang H; He J; Yin W
    Thorac Cancer; 2019 Apr; 10(4):823-831. PubMed ID: 30779318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
    Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
    BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.
    Wu DW; Chang WA; Liu KT; Yen MC; Kuo PL
    Oncol Lett; 2017 Sep; 14(3):3657-3662. PubMed ID: 28927127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 35. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions.
    Park DS; Hwang KE; Shim H; Kim BR; Choi KH; Park SH; Park SD; Jeong ET; Kim HR
    Clin Exp Metastasis; 2012 Feb; 29(2):83-9. PubMed ID: 22045227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
    Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
    Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients.
    Zhao F; An R; Wang L; Shan J; Wang X
    Front Cell Infect Microbiol; 2021; 11():725284. PubMed ID: 34527604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
    Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
    Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleural effusions associated with squamous cell lung carcinoma have a low diagnostic yield and a poor prognosis.
    Dorry M; Davidson K; Dash R; Jug R; Clarke JM; Nixon AB; Mahmood K
    Transl Lung Cancer Res; 2021 Jun; 10(6):2500-2508. PubMed ID: 34295657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.